IP Library › Granted Patent US 9,457,053
Granted Patent B2
US 9,457,053 · App. 14/090,804 · Granted Oct 4, 2016

Methods of differentiating stem cells by modulating MIR-124

Inventors: Jau-Nan Lee (Kaohsiung, TW); Tony Tung-Yin Lee (Yarrow Point, WA); Yuta Lee (Kaohsiung, TW)
Assignee: ACCELERATED BIOSCIENCES CORP.
A61K35/39C12N5/0605G01N33/507G01N33/5073C12N2501/115C12N2501/65
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,457,053
App. No.
14/090,804
Granted
Oct 4, 2016
Kind
B2
Abstract

Provided herein are methods of differentiating stem cells via modulating miR-124, and the differentiated cells thereby. Also provided herein are methods for the treatment of diseases using the differentiated cells.

Claims (14)

1. A method of differentiating an isolated mammalian trophoblast stem cell, the method comprising contacting the isolated mammalian trophoblast stem cell with bFGF (basic fibroblast growth factor), 2-mercaptoethanol and nicotinamide, to induce differentiation of the isolated mammalian trophoblast stem cell to a pancreatic progenitor cell that expresses a marker selected from the group consisting of Ngn3, insulin, and a combination thereof, wherein the isolated mammalian trophoblast stem cell is from a human or a mouse.

2. The method of claim 1 , wherein the isolated mammalian trophoblast stem cell is a human trophoblast stem cell (hTS cell).

3. The method of claim 1 , wherein the method activates miR-124.

4. The method of claim 1 , wherein the concentration of bFGF is no more than 100 ng/mL.

5. The method of claim 1 , wherein the concentration of bFGF is from about 1 to about 100 ng/mL.

6. The method of claim 1 , wherein the concentration of bFGF is about 10 ng/mL.

7. The method of claim 1 , wherein the concentration of 2-mercaptoethanol is from about 0.1 to about 10 mmol/L.

8. The method of claim 7 , wherein the concentration of 2-mercaptoethanol is about 1 mmol/L.

9. The method of claim 1 , wherein the concentration of nicotinamide is from about 1 to about 100 mmol/L.

10. The method of claim 9 , wherein the concentration of nicotinamide is about 10 mmol/L.

11. The method of claim 3 , wherein the miR-124 is miR-124a.

12. The method of claim 3 , wherein the miR-124 is homo sapiens miR-124a (hsa-miR-124a).

13. The method of claim 3 , wherein the miR-124 is hsa-miR-124-5p (SEQ ID NO:1: CGUGUUCACAGCGGACCUUGAU) or a fragment thereof; or hsa-miR-124-3p (SEQ ID NO:2: UAAGGCACGCGGUGAAUGCC) or a fragment thereof.

14. The method of any one of claim 1 , 2 , 3 , 4 - 6 , or 7 - 13 , wherein the pancreatic progenitor cell expresses Ngn3.

Assignments (2)
CHANGE OF ADDRESS Recorded Jun 7, 2017
From: ACCELERATED BIOSCIENCES CORP.
To: ACCELERATED BIOSCIENCES CORP.
Reel/Frame 043279/0971 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 27, 2014
From: LEE, JAU-NAN; LEE, TONY TUNG-YIN; LEE, YUTA
To: ACCELERATED BIOSCIENCES CORP.
Reel/Frame 032312/0412 →
Continuity (3)
Provisional Application 61732162 · Nov 30, 2012
Provisional Application 61877156 · Sep 12, 2013
Related Publication 20140170118A1 · Jun 19, 2014